Immunic Q1 EPS $(0.58) Misses $(0.52) Estimate; $97.1M In Cash, Cash Equivalents & Investments Expected to Fund Immunic Into Q4 Of 2024

Benzinga · 05/11/2023 06:38
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 21.62 percent increase over losses of $(0.74) per share from the same period last year.